中文
English| 項目 | 內容 |
|---|---|
| 時間 | 2024-03-23的14:30至 2024-03-24的12:35 |
| 類型 | 丙類 |
| 積分 | 1.5 |
| 主辦單位 | 台灣諾華股份有限公司 |
| 會議地點 | 台中日月千禧酒店5樓 VEE5 |
Novartis Hematology Forum-Reimagine medicine
Novartis Hematology Forum-Reimagine medicine
節目表
GvHD
GvHD
- Exploring Real-World Data on Ruxolitinib for GvHD:Sharing Experiences at NTUH
- Enhancing Chronic GvHD Outcomes:A Practical Strategy in Current National Health Insurance Framework
- Optimizing Lung GvHD Outcomes: A Multidisciplinary Approach from a Pulmonologist’s Perspective
- Serving as an Advocate and Coordinator for GvHD Patients: The Application of the TBMT HSCT App in Clinical Practice
- Explore the novel agent: Scemblix case sharing
- CGMH CML treatment experience sharing
- Optimizing CAR-T Cell Therapy in Lymphoma: Harnessing Real-World Data Insights
- Strategic Advancements in Pediatric/AYA B-ALL CAR-T Cell Therapy: A Real-world Data Perspective
- Real-world data of aplastic anemia and efficacy of Revolade in Taiwan
- A retrospective and prospective analysis of the optimal treatment duration in myelofibrosis (MF)